Taiwan FDA registration 3b648f6b8ae74442dcb271701570b2a3
"MP" Insulin Test (Non-Sterile)
TW: "馬丁彼得" 胰島素檢驗試劑 (未滅菌)
Taiwan·Risk Class 1·MD·MP BIOMEDICALS DIAGNOSTICS DIVISION·Registered Jul 21, 2014 – Jul 21, 2024ExpiredRegistration details
- Analysis ID
- 3b648f6b8ae74442dcb271701570b2a3
- License Form
- Ministry of Health Medical Device Import No. 014347
- Customs Code
- DHA09401434701
Company information
- Manufacturer
- MP BIOMEDICALS DIAGNOSTICS DIVISION
- Manufacturer Country
- United States
- Authorized Representative
- GENERAL BIOLOGICALS CORP.
Product details
- Intended Use
- Limited to the first level identification range of the immunoresponsive insulin test system (A.1405) of the management method for medical devices.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1405 Immunoresponsive Insulin Test System
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jul 21, 2014
- Expiry Date
- Jul 21, 2024
About this record
Access comprehensive regulatory information for "MP" Insulin Test (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 3b648f6b8ae74442dcb271701570b2a3 and manufactured by MP BIOMEDICALS DIAGNOSTICS DIVISION. The authorized representative in Taiwan is GENERAL BIOLOGICALS CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices